Harmony Biosciences Hldg Inc (HRMY)
$38.76 +0.44% Close Oct 30, 2026 Live
Harmony Biosciences Hldg stock today
Harmony Biosciences Hldg closed at $38.76 on October 30, 2026, up 0.44% on the day. Over the past year it returned +34.1% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.24 billion.
$30.00$35.00$40.00
NovJan 2026MarMayJulSep
| Period | HRMY | S&P 500 (SPY) |
|---|---|---|
| 1 month | -1.3% | -0.9% |
| 3 months | +8.1% | +2.1% |
| Year to date | +3.6% | +11.7% |
| 1 year | +34.1% | +12.4% |
| 3 years | +96.7% | +88.5% |
| 5 years | -6.5% | +76.0% |
Key statistics
- Market value
- $2.24B
- P/E (trailing)
- 12.6
- Forward P/E
- 6.3
- Price / sales
- 2.3
- 52-week range
- $26.54 to $42.86
- Next report
- Nov 4, 2026
About Harmony Biosciences Hldg
Biopharmaceutical company developing and commercializing treatments for neurological disorders.
Sector: Health Care
More on Harmony Biosciences Hldg
- Financials: revenue, earnings and segmentsRevenue +22% in the year to Dec 2025
- Valuation: P/E history and peersP/E 12.6, median 15.2 at its last 5 year ends
- Returns: what $1,000 became$1,000 five years ago is $934.65 today
No forecast, no recommendation. This page describes Harmony Biosciences Hldg Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.